Under pathological conditions, ALDH2 expression level is elevated, competitively decreasing the binding between LIN28B and ELK3 mRNA, thereby destabilizing ELK3 mRNA and inhibiting endothelial barrier gene expression, which promotes endothelial hyperpermeability and accelerates the development of early AAA. The gene discussed is ALDH2; the disease is triple-A syndrome.